Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04900935 · ClinicalTrials.gov registry record · NA
Patient-centered, Optimal Integration of Survivorship and Palliative Care
A NA study of Carcinoma, Non-Small Cell Lung and Survivorship, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04900935 is a NA study of Carcinoma, Non-Small Cell Lung and Survivorship that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 70 participants, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04900935, a NA study of Carcinoma, Non-Small Cell Lung and Survivorship, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC). The main questions are * is POISE feasible to deliver and acceptable to patients * what is the effect of POISE on the distress patients feel related to their uncertain future, their confidence in their ability to manage cancer, and their understanding about what to expect Participants in the randomized controlled trial will receive either the new supportive care model, POISE, which consists of four visits with a trained palliative care clinician, or care as usual, and will be asked to complete three surveys.
Conditions Studied
Interventions
- BEHAVIORAL POISE
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-09-29 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04900935
The ClinicalTrials.gov registry entry for NCT04900935 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (78% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 1 intervention - of which POISE is the first listed.
NCT04900935 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04900935 about?
NCT04900935 is a clinical study titled "Patient-centered, Optimal Integration of Survivorship and Palliative Care". The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC). The main questions are * is POISE feasible to deliver and acceptable to patients * what is the effect of POISE on the distress patients f...
What is the current status of trial NCT04900935?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-09-29. Estimated completion is 2027-09-01.
What conditions does trial NCT04900935 study?
This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung, Survivorship, Stage IV Non-small Cell Lung Cancer, Palliative Care, Nonsmall Cell Lung Cancer.
What interventions are being tested in trial NCT04900935?
The interventions under investigation include: POISE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04900935?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04900935 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma, Non-Small Cell Lung
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Confocal Laser Endomicroscopy VERification
RECRUITING · NA
-
Once Weekly Radiation for Lung Cancer With Chemotherapy
COMPLETED · NA
-
Healthy Directions After Lung Surgery Pilot
COMPLETED · NA
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RECRUITING · Phase 1
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.